THC / cannabis products
Sleep & Recovery · Cannabinoid / THC agonist
Tier C-
Bottom line
Read Off Label grades THC / cannabis products as C- (4.1/10) based on weak-mixed evidence, low-med benefit magnitude, and a med-risk safety profile.
WADA coverage: cannabis/hashish/marijuana and cannabis products, natural tetrahydrocannabinols/THCs, synthetic tetrahydrocannabinols/THCs and synthetic cannabinoids that mimic THC.
Studied, labeled, or reported-use context: Medical/recreational dosing varies by product; no universal dose — Legal status varies by jurisdiction; THC/cannabis WADA S8 prohibited in competition; CBD is an exception; not individualized guidance.
What the evidence says
WADA coverage: cannabis/hashish/marijuana and cannabis products, natural tetrahydrocannabinols/THCs, synthetic tetrahydrocannabinols/THCs and synthetic cannabinoids that mimic THC. CBD already has its own row and is a WADA exception, though products can be contaminated with THC. Additional WADA alias coverage: Synthetic cannabinoids that mimic the effects of THC.
Mechanism
THC-containing cannabis products are used for sleep, pain, appetite and anxiety, but evidence is mixed and dose-response is often biphasic.
Studied, labeled, or reported dose & route
Medical/recreational dosing varies by product; no universal dose
This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.
Citations
A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.
Common questions
- What does the evidence show about THC / cannabis products's effects?
- Read Off Label rates the evidence for THC / cannabis products as Weak-Mixed and the benefit magnitude as low-med, producing an overall grade of C- (4.1/10). WADA coverage: cannabis/hashish/marijuana and cannabis products, natural tetrahydrocannabinols/THCs, synthetic tetrahydrocannabinols/THCs and synthetic cannabinoids that mimic THC.
- What safety findings are reported for THC / cannabis products?
- THC / cannabis products has a med risk profile in the database. Med (anxiety/paranoia, impaired driving/cognition, dependence, sleep-architecture changes, psychosis risk in susceptible users) Legal status: Legal status varies by jurisdiction; THC/cannabis WADA S8 prohibited in competition; CBD is an exception.
- What doses or routes are reported for THC / cannabis products?
- Medical/recreational dosing varies by product; no universal dose This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
- How does THC / cannabis products work?
- THC-containing cannabis products are used for sleep, pain, appetite and anxiety, but evidence is mixed and dose-response is often biphasic.
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.